Several types of arthritis fall under the JIA heading. This inflammation begins before patients reach the age of 16 years, and may involve one or many joints and cause other symptoms such as fevers, rash, and eye inflammation.
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
A Unique Structure for Tackling Psoriatic Disease
GRAPPA brings together a group of highly motivated physicians to address these complex disorders
Psoriatic Arthritis: From Leeds to the Limelight
Advances in understanding of the disease begin in the 1960s
Science from our Sisters
Recommended reading from A&R and AC&R
- « Previous Page
- 1
- …
- 15
- 16
- 17